Article

Evaluation of SARS-CoV-2 Antibody Point of Care Devices in the Laboratory and Clinical Setting

2021-12-16

Abstract excerpt

SARS-CoV-2 Antibody tests have been marketed to diagnose previous SARS-CoV-2 infection and as a test of immune status. There is a lack of evidence on the performance and clinical utility of these tests. We aimed to carry out an evaluation of 14 point of care (POC) SARS-CoV-2 antibody tests. Serum from participants with previous RT-PCR (Real-Time Polymerase chain reaction) confirmed SARS-CoV-2 infection and pre-pan...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 171b2fca-6147-5201-8d5a-c7a2b73cece6
DOI: 10.1101/2021.12.16.21267703

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of SARS-CoV-2 Antibody Point of Care Devices in the Laboratory and Clinical SettingDOI 10.1101/2021.12.16.21267703Read

Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19Semantic proximity Read

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Semantic proximity Read

Point-of-care serological assays for SARS-CoV-2 in a UK hospital population: potential for enhanced case findingSemantic proximity Read

Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratorySemantic proximity Read

Evaluating ten commercially-available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) methodSemantic proximity Read

Enzyme immunoassay for SARS-CoV-2 antibodies in dried blood spot samples: A minimally-invasive approach to facilitate community- and population-based screeningSemantic proximity Read

Clinical and experimental factors that affect the reported performance characteristics of rapid testing for SARS-CoV-2Semantic proximity Read

Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence populationSemantic proximity Read

Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: results from a pilot serviceSemantic proximity Read

Diagnostic accuracy of three prevailing rapid antigen tests for detection of SARS-CoV-2 infection in the general population: cross sectional studySemantic proximity Read

Performance Assessment of First-Generation Anti-SARS-CoV-2 Serological AssaysSemantic proximity Read

Clinical Assessment of the Roche SARS-CoV-2 Rapid Antigen TestSemantic proximity Read